Business
GoodRx Reports Fourth Quarter and Full Year 2022 Results
Fourth quarter financial results exceed previously announced guidance SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading
About this update from Goodrx Holdings, Inc.
[{"type":"text","content":"\nFourth quarter financial results exceed previously announced guidance\n\n SANTA MONICA, Calif.--(BUSINESS WIRE)--\nGoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, has released its financial results for the fourth quarter and full year 2022.\n\nFourth Quarter 2022 Highlights\n\n\nTotal revenue of $184.1 million, exceeding previously announced guidance\n\n\nNet loss of $2.01 million; Net loss margin of 1.1%\n\n\nAdjusted Net Income2 of $27.4 million; Adjusted Net Income Margin2 of 14.9%\n\n\nAdjusted EBITDA2 of $49.6 million; Adjusted EBITDA Margin2 of 26.9%, exceeding previously announced guidance\n\n\nNet cash provided by operating activities of $31.9 million\n\n\nApproximately 900,000 prescribers active on GoodRx in the last 19 months3\n\n\nExited the quarter with over 7 million consumers of prescription-related offerings4\n\n\nFull Year 2022 Highlights\n\n\nTotal revenue of $766.6 million\n\n\nNet loss of $32.81 million; Net loss margin of 4.3%\n\n\nAdjusted Net Income2 of $125.8 million; Adjusted Net Income Margin2 of 16.4%\n\n\nAdjusted EBITDA2 of $213.5 million; Adjusted EBITDA Margin2 of 27.8%\n\n\nNet cash provided by operating activities of $146.8 million\n\n\n“In the fourth quarter, we delivered revenue of $184 million, which was ahead of our fourth quarter guidance led by another strong quarter in our subscription offerings, which grew 42% year-over-year. Our core prescription transactions offering came in slightly ahead of our expectations despite being impacted by the grocer issue, and our profitability also surpassed our internal expectations for the second quarter in a row,” said Doug Hirsch, co-CEO and co-founder of GoodRx. “We continued to make important strides in improving our efficiency, as we strengthened and added to our retail and provider networks, and leveraged innovation to increase our relevancy with both consumers and providers while expanding healthcare access to millions of Americans.”\n\n“Over 7 million Americans used GoodRx for their healthcare needs in the fourth quarter across our prescription related offerings, and our industry leading brand and scale remain key competitive differentiators for us. As we expand our healthcare provider and consumer offerings across our platform, we expect to build on our strong foundation and grow profitability as our value propositi...